Driving Innovation in Clinical Genomics
OICR Genomics accelerates clinical oncology research through partnerships that drive innovation in clinical genomics.
We prioritize clinical laboratory and computational capabilities to validate novel oncology assays with rich clinical annotation. We provide rapid targeted sequencing of clinical samples for application in precision medicine activities. We follow best practices through our ISO 15189-compliant Quality Management System.
Sequencing for Precision Medicine Research
The OICR Genomics Program is much more than a sequencing core facility.
We pride ourselves in being a technology platform that can help scientists solve biological problems from start to finish. We focus our capabilities in the area of human cancers, with proven success in generating reliable results from low input and/or low quality biospecimens.
Tailored Data Analysis Workflows
The Bioinformatics group is a dedicated team of bioinformatics analysts with access to a 6,200+ thread computational cluster.
We develop and utilize a variety of automated and semi-automated analysis workflows to fulfill every project’s unique needs. Quality control checks and analysis are performed specific to each project.
Our Expert Leaders
Trevor Pugh, PhD
Joint Genomics Program, OICR
Paul Krzyzanowski, PhD, MBA
Genome Research Platform, OICR
Morgan Taschuk, MSc
Genome Sequence Informatics (GSI), OICR
Troy Ketela, PhD
Princess Margaret Genomics Centre (PMGC)
Dax Torti, PhD
Translational Genomics Laboratory, OICR
Carolyn Ptak, PhD, PMP, CMQ/OE
Quality Assurance and Program Management, OICR